A Closer Look at AbbVie-Allergan Deal and Where Eye Care Fits In

A Closer Look at AbbVie-Allergan Deal and Where Eye Care Fits In

NEW YORK – In what’s been called “a transformative move for both companies,” AbbVie has agreed to buy Allergan in a deal valued at $63 billion. Reaction from the investor community was deeply mixed. The announcement on Tuesday set off the worst day for AbbVie’s stock since it was spun off from its parent company,…

Read More